Mesa Laboratories (MLAB) risk factors

Item 1A of every Mesa Laboratories Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open MLAB in Gloom →

Mesa Laboratories' chart, financials and news, free in your browser.Open MLAB in Gloom →

FY2026 10-K risk factors
49 risks12 new11 dropped37 reworded
New risks focus on supply-chain disruption, tariffs, FDA and cybersecurity compliance, and the March 2026 CEO transition.
Filed Jun 03, 2026
FY2025 10-K risk factors
48 risks
Mesa Laboratories faces intense market competition, strict FDA and international regulatory requirements, and integration risks from strategic business acquisitions. Significant revenue concentration relies on key customers, distributors, and specific product lines like Dialyguard.
Filed May 28, 2025